Lavanga (Syzygium aromaticum)

Lavanga, derived from the dried flower buds of Syzygium aromaticum (clove), is rich in eugenol, a phenylpropanoid compound that inhibits cyclooxygenase enzymes and modulates NF-κB signaling to produce anti-inflammatory and hepatoprotective effects. Eugenol also exhibits potent antioxidant activity by scavenging free radicals and chelating metal ions, underpinning its broad therapeutic applications in Ayurvedic medicine.

Origin & History

Lavanga (Syzygium aromaticum) is derived from the dried flower buds of an evergreen tree native to the Maluku Islands of Indonesia and widely cultivated in tropical regions. The buds are harvested before flowering, dried, and processed through steam distillation for essential oil or aqueous/infusion methods for extracts, with eugenol as the dominant bioactive constituent.

Historical & Cultural Context

Syzygium aromaticum has been used for millennia as a spice, food preservative, and medicinal plant in global traditional systems, particularly valued for its antimicrobial and anti-inflammatory properties. Its use spans from ancient Indonesian origins to widespread adoption across various cultures for both culinary and therapeutic applications.

Health Benefits

• Anti-inflammatory effects: Aqueous extract (200 mg/kg) reduced lung inflammation markers in mice, lowering bronchoalveolar lavage fluid protein content and neutrophil recruitment (p<0.05) - preliminary animal evidence
• Liver protection: Eugenol-rich fraction reversed thioacetamide-induced liver cirrhosis in rats, reducing liver weight-body weight ratio and serum ALP/GGT levels - preliminary animal evidence
• Antioxidant activity: Inhibited lipid peroxidation and restored glutathione (GSH) levels in rat liver studies - preliminary evidence
• Antimicrobial properties: Essential oil demonstrated activity against Gram-positive and Gram-negative bacteria including E. coli - in vitro evidence
• Neutrophil modulation: Inhibited neutrophil oxidant production including superoxide and myeloperoxidase activity in vitro - preliminary evidence

How It Works

Eugenol, the primary bioactive constituent of Lavanga (comprising up to 72–90% of clove essential oil), inhibits cyclooxygenase-1 and cyclooxygenase-2 (COX-1/COX-2) enzymes, thereby reducing prostaglandin E2 synthesis and attenuating the inflammatory cascade. Eugenol also suppresses NF-κB pathway activation by blocking IκB kinase phosphorylation, which downregulates pro-inflammatory cytokines including TNF-α and IL-6. Additionally, eugenol acts as a potent antioxidant by donating hydrogen atoms to reactive oxygen species and upregulating endogenous antioxidant enzymes such as superoxide dismutase and catalase, contributing to its hepatoprotective properties.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for Lavanga. Available evidence is limited to preclinical studies including mouse models (n=8-10 per group) demonstrating anti-inflammatory effects and rat studies (n=5 per group) showing liver protective properties over 9 weeks of treatment.

Clinical Summary

Preclinical animal studies provide the strongest current evidence for Lavanga's benefits: an aqueous extract at 200 mg/kg significantly reduced bronchoalveolar lavage fluid protein content and neutrophil recruitment in a murine lung inflammation model (p<0.05), indicating anti-inflammatory efficacy. An eugenol-rich fraction has also demonstrated reversal of thioacetamide-induced hepatotoxicity in rodents, reducing markers of liver cell damage including elevated transaminases. Human clinical evidence remains limited, with small-scale studies suggesting clove extract may reduce oxidative stress biomarkers and improve glycemic markers, but these trials typically involve fewer than 50 participants and lack rigorous controls. Overall, the evidence is preliminary and largely preclinical; robust randomized controlled trials in humans are needed before definitive therapeutic claims can be made.

Nutritional Profile

Lavanga (Syzygium aromaticum / Cloves) per 100g dried whole cloves: Macronutrients - Calories: ~274 kcal; Carbohydrates: ~65g (dietary fiber: ~33g, comprising largely insoluble cellulose and hemicellulose); Protein: ~6g; Fat: ~13g (primarily palmitic acid, oleic acid, linoleic acid). Micronutrients - Manganese: ~60mg (3000% DV, exceptionally high); Vitamin K: ~141.8mcg; Vitamin C: ~11.7mg; Vitamin E: ~8.8mg (alpha-tocopherol); Magnesium: ~259mg; Calcium: ~632mg (bioavailability limited due to oxalate content); Potassium: ~1020mg; Phosphorus: ~104mg; Iron: ~11.8mg; Zinc: ~2.3mg; Copper: ~0.37mg. Bioactive Compounds - Eugenol: 72-90% of volatile essential oil content (primary bioactive; essential oil yield ~15-20% of dry weight); Eugenol acetate: 5-15% of essential oil; Beta-caryophyllene: 5-12% of essential oil (sesquiterpene with anti-inflammatory properties); Alpha-humulene: ~1-2% of essential oil; Acetyl eugenol: present in bud oil at ~2%; Phenolic compounds total: ~9,188mg gallic acid equivalents/100g (one of highest among spices); Flavonoids: kaempferol, quercetin, myricetin present at ~1-2mg/g dry weight; Triterpenoids: oleanolic acid, ursolic acid (~0.5-1mg/g); Tannins: ~9g/100g (including ellagitannins such as casuarictin and tellimagrandin). Bioavailability Notes - Eugenol is rapidly absorbed through gastrointestinal tract with peak plasma levels within 1-2 hours post-ingestion; high tannin and fiber content may reduce mineral (iron, calcium, zinc) bioavailability by 30-50%; essential oil constituents show enhanced bioavailability when consumed with lipid-containing foods; manganese absorption estimated at 3-8% of total content due to competing dietary factors.

Preparation & Dosage

No clinically studied human dosages are available. Animal studies used aqueous extract at 200 mg/kg intraperitoneally in mice and eugenol-rich fraction at 80 mg/100g body weight orally (approximately 800 mg/kg) in rats for 9 weeks. No standardization details or human dosage ranges have been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric, Ginger, Black Pepper, Ashwagandha, Milk Thistle

Safety & Interactions

Lavanga and its isolated eugenol are generally considered safe at culinary doses, but concentrated clove oil or high-dose eugenol supplements (above 2.6 mg/kg/day, the established tolerable daily intake) can cause hepatotoxicity, mucous membrane irritation, and contact dermatitis. Eugenol inhibits platelet aggregation and may potentiate the effects of anticoagulant and antiplatelet medications such as warfarin and aspirin, increasing bleeding risk. Clove oil may also interact with cytochrome P450 enzymes (particularly CYP1A2 and CYP3A4), potentially altering the metabolism of drugs processed by these pathways. Lavanga is not recommended in therapeutic doses during pregnancy due to potential uterine-stimulating effects, and individuals with liver disease should exercise caution given eugenol's dose-dependent hepatotoxic potential at elevated concentrations.